Successful renal transplant outcome after intravenous gamma-globulin treatment of a highly sensitized pediatric recipient

Pediatric Transplantation

Volumn 6, Issue 2, 2002, Pages 161-165

  Al Uzri, Amira Y ^a,e   Seltz, Barry ^b   Yorgin, Peter D ^c   Spier, Catherine M ^b   Andreoni, Kenneth ^d  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c STANFORD UNIVERSITY   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Child; HLA antigens; Kidney transplantation; Lymphocyte cross match; Panel reactive antibodies; Tacrolimus

Indexed keywords

ANTIIDIOTYPIC ANTIBODY; CYTOTOXIC ANTIBODY; DIPHENHYDRAMINE; HLA ANTIBODY; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PARACETAMOL; PREDNISONE; SULTAMICILLIN; TACROLIMUS; THYMOCYTE ANTIBODY; VANCOMYCIN;

ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CADAVER DONOR; CASE REPORT; DRUG HYPERSENSITIVITY; DRUG INFUSION; DRUG MECHANISM; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; NEWBORN; PLASMAPHERESIS; POSTOPERATIVE PERIOD; TREATMENT FAILURE;

ABNORMALITIES; CHILD; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT, NEWBORN; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; TRANSPLANTATION IMMUNOLOGY; TREATMENT OUTCOME;

EID: 0036246177     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3046.2002.01055.x     Document Type: Article

References (34)

1. The UNOS Scientific Renal Transplant Registry
2. The UNOS Scientific Renal Transplant Registry
3. Pretransplantation immunoadsorption therapy in patients immunized with human lymphocyte antigen: Effect of treatment and three years' clinical follow-up of grafts
4. Plasmapheresis in HLA-immunosensitized patients prior to kidney transplantation
5. Plasma exchange and immunosuppressive therapy before renal transplantation in highly sensitized patients
6. Donor pretreatment as an adjunct to cadaver renal allotransplantation
7. Removal of anti-HLA antibodies by extracorporeal immunoadsorption to enable renal transplantation
8. Successful transplantation in highly sensitized patients
9. Extracorporeal removal of anti-HLA antibodies in transplant candidates
10. Outcome of renal transplantation after DFPP treatment in presensitized recipients
11. Removal of preformed cytotoxic antibody using PROSORBA (Staph Protein-A-Silica) column without immunosuppression
12. Plasmapheresis, intravenous cytomegalovirus-specific immunoglobulin and reversal of antibody-mediated rejection in a pediatric renal transplant recipient: A case report
13. Treatment of acute humoral rejection in kidney transplantation with plasmapheresis
14. Plasma exchange and tacrolimus-mycophenolate rescue for acute humoral rejection in kidney transplantation
15. Immunoadsorption with protein A in humoral rejection of kidney transplants
16. Plasma exchange in highly sensitized patients as induction therapy after renal transplantation
17. Value of plasma exchange in renal transplant rejection induced by specific anti-HLA antibodies
18. Successful kidney transplantation of immunized patients after desensitization with normal human polyclonal immunoglobulins
19. Immunomodulatory actions of intravenous immunoglobulin (IVIG): Potential applications in solid organ transplant recipients
20. Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action
21. Inhibition of allospecific responses in the mixed lymphocyte reaction by pooled human gamma-globulin
22. Intravenous immunoglobulin suppression of HLA alloantibody in highly sensitized transplant candidates and transplantation with a histoincompatible organ
23. Successful kidney transplantation after suppression of HLA alloantibodies with intravenous immunoglobulin in a highly sensitized patient
24. Use of intravenous immunoglobulin in organ transplantation for noninfectious indications
25. Suppression of HLA-specific alloantibodies by high-dose intravenous immunoglobulins (IVIg). A potential tool for transplantation of immunized patients
26. Pretransplant removal of anti-HLA antibodies by plasmapheresis and continued suppression on cyclosporine-based therapy after heart-kidney transplant
27. Immunoglobulin i.v. high dose (IVIgHD): New therapy as a rescue treatment of grafted kidneys
28. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients
29. In vivo modulation of cytokine synthesis by intravenous immunoglobulin
30. Mechanisms of action of intravenous immune globulin in immune-mediated diseases
31. High doses of intravenous Ig inhibit in vitro uptake of C4 fragments onto sensitized erythrocytes
32. Complementary data about the inhibitory effects of intravenous immunoglobulins in vitro and in vivo
33. Pediatric renal transplantation under tacrolimus-based immunosuppression
34. A randomized and prospective study comparing treatment with high-dose intravenous immunoglobulin with monoclonal antibodies for rescue of kidney grafts with steroid-resistant rejection